Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > Global
Category: All Categories > Life Sciences > Pharmaceuticals > Diseases & Conditions > Parkinson's Disease
(11 reports matching your criteria)
 
Parkinson's Disease Global Clinical Trials Review, H2, 2012
10/31/2012 | published by: GlobalData
... and data relating to the clinical trials on Parkinson’s Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  read more...
$2,500.00
Vaccines 2012-16 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments
9/19/2012 | published by: Kalorama Information
... emerging vaccines for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETEC infection, heart attach, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, West Nile virus (WNV) ...  |  read more...
$1,500.00
Analyzing the Global CNS Market
9/1/2012 | published by: Aruvian's R'search
... development. This is largely due to significant levels of unmet medical need and the clinical specificity of many CNS drugs. The CNS disorders market may be segmented into numerous subcategories, including Alzheimer's disease (AD), epilepsy, ...  |  read more...
$650.00
Global Markets for Treatments of Dementia and Movement Disorders - Focus on Movement Disorders
9/1/2012 | published by: BCC Research
... in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8.5%. Treatments for movement disorders are expected to be worth $3.2 billion in 2012 and $4.8 billion in 2017, a CAGR of ...  |  read more...
$4,400.00
Neuroprotective Products: World Market Prospects 2012-2022
5/10/2012 | published by: Visiongain
... projected sales at overall world market, therapeutic submarket and product level to 2022. The protection of nerve tissues is becoming more important. You can assess the potential for drug revenues there, as well as finding ...  |  read more...
$2,739.00
Parkinson's Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
1/31/2012 | published by: GlobalData
... The report is an essential source of information and analysis on the global Parkinson’s Disease (PD) therapeutics market. It provides comprehensive market information, highlighting the treatment guidelines and identifying and analyzing the key trends shaping ...  |  read more...
$6,995.00
Parkinson's Disease: World Drug Market 2011-2021
9/26/2011 | published by: Visiongain
... world, submarket, product and national levels to 2021? Through our research and analysis we aim to save you time and help in your decisions. Find out how the drugs Stalevo/Comtess, Sifrol, Azilect and Requip can ...  |  read more...
$2,739.00
Neurodegenerative Drugs
4/1/2010 | published by: Global Industry Analysts
... analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2006 through 2015. The report profiles 165 companies including many key and niche players ...  |  read more...
$3,950.00
Global Neuromodulation Market 2009-2013
2/24/2010 | published by: Infiniti Research Limited
... ailments and psychiatric illnesses. It is widely used for the treatment of chronic conditions such as lower back pain, urinary incontinence, Parkinson's disease, tremor, epilepsy, depression, etc. Advancement in technology and greater knowledge in neurophysiology ...  |  read more...
$1,500.00
Alzheimer's and Parkinson's Disease
5/1/2008 | published by: Global Industry Analysts
... Agonists, & Other PD Drugs (Include COMT Inhibitors, MOA-B Inhibitors, and Dopamine Amplifiers). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each ...  |  read more...
$3,950.00
Parkinson's Disease Selections from "The World Market for Neurotherapeutic Drugs"
11/1/2002 | published by: Kalorama Information
... the breadth and authority of the results proved to be more information than some marketers needed. Smaller biopharmaceutical concerns—some of the real drivers of this market—are more focused on individual neurological disorders such as multiple ...  |  read more...
$1,121.00